000834120 001__ 834120
000834120 005__ 20210129230544.0
000834120 0247_ $$2doi$$a10.1093/neuonc/nox112
000834120 0247_ $$2ISSN$$a1522-8517
000834120 0247_ $$2ISSN$$a1523-5866
000834120 0247_ $$2pmid$$apmid:28605532
000834120 0247_ $$2WOS$$aWOS:000417204200010
000834120 0247_ $$2altmetric$$aaltmetric:29918857
000834120 037__ $$aFZJ-2017-04120
000834120 041__ $$aEnglish
000834120 082__ $$a610
000834120 1001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b0$$eCorresponding author$$ufzj
000834120 245__ $$aPET Imaging in Patients with Meningioma - Report of the RANO/PET Group
000834120 260__ $$aOxford$$bOxford Univ. Press$$c2017
000834120 3367_ $$2DRIVER$$aarticle
000834120 3367_ $$2DataCite$$aOutput Types/Journal article
000834120 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1512117526_28138
000834120 3367_ $$2BibTeX$$aARTICLE
000834120 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000834120 3367_ $$00$$2EndNote$$aJournal Article
000834120 520__ $$aMeningiomas are the most frequent nonglial primary brain tumors and represent about 30% of brain tumors. Usually, diagnosis and treatment planning are based on neuroimaging using mainly MRI or, rarely, CT. Most common treatment options are neurosurgical resection and radiotherapy (eg, radiosurgery, external fractionated radiotherapy). For follow-up after treatment, a structural imaging technique such as MRI or CT is used. However, these structural imaging modalities have limitations, particularly in terms of tumor delineation as well as diagnosis of posttherapeutic reactive changes. Molecular imaging techniques such as PET can characterize specific metabolic and cellular features which may provide clinically relevant information beyond that obtained from structural MR or CT imaging alone. Currently, the use of PET in meningioma patients is steadily increasing. In the present article, we provide recommendations for the use of PET imaging in the clinical management of meningiomas based on evidence generated from studies being validated by histology or clinical course.
000834120 536__ $$0G:(DE-HGF)POF3-573$$a573 - Neuroimaging (POF3-573)$$cPOF3-573$$fPOF III$$x0
000834120 588__ $$aDataset connected to CrossRef
000834120 7001_ $$0P:(DE-HGF)0$$aAlbert, Nathalie L.$$b1
000834120 7001_ $$0P:(DE-HGF)0$$aSommerauer, Michael$$b2
000834120 7001_ $$0P:(DE-HGF)0$$aGrosu, Anca L.$$b3
000834120 7001_ $$0P:(DE-HGF)0$$aGanswindt, Ute$$b4
000834120 7001_ $$0P:(DE-HGF)0$$aLaw, Ian$$b5
000834120 7001_ $$0P:(DE-HGF)0$$aPreusser, Matthias$$b6
000834120 7001_ $$0P:(DE-HGF)0$$aLe Rhun, Emilie$$b7
000834120 7001_ $$0P:(DE-HGF)0$$aVogelbaum, Michael A.$$b8
000834120 7001_ $$0P:(DE-HGF)0$$aZadeh, Gelareh$$b9
000834120 7001_ $$0P:(DE-HGF)0$$aDhermain, Fr?d?ric$$b10
000834120 7001_ $$0P:(DE-HGF)0$$aWeller, Michael$$b11
000834120 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b12$$ufzj
000834120 7001_ $$0P:(DE-HGF)0$$aTonn, J?rg C.$$b13
000834120 773__ $$0PERI:(DE-600)2094060-9$$a10.1093/neuonc/nox112$$n12$$p1576–1587$$tNeuro-Oncology$$v19$$x1523-5866$$y2017
000834120 8564_ $$uhttps://juser.fz-juelich.de/record/834120/files/nox112.pdf$$yRestricted
000834120 8564_ $$uhttps://juser.fz-juelich.de/record/834120/files/nox112.gif?subformat=icon$$xicon$$yRestricted
000834120 8564_ $$uhttps://juser.fz-juelich.de/record/834120/files/nox112.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000834120 8564_ $$uhttps://juser.fz-juelich.de/record/834120/files/nox112.jpg?subformat=icon-180$$xicon-180$$yRestricted
000834120 8564_ $$uhttps://juser.fz-juelich.de/record/834120/files/nox112.jpg?subformat=icon-640$$xicon-640$$yRestricted
000834120 8564_ $$uhttps://juser.fz-juelich.de/record/834120/files/nox112.pdf?subformat=pdfa$$xpdfa$$yRestricted
000834120 909CO $$ooai:juser.fz-juelich.de:834120$$pVDB
000834120 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b0$$kFZJ
000834120 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b12$$kFZJ
000834120 9131_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000834120 9141_ $$y2017
000834120 915__ $$0StatID:(DE-HGF)0400$$2StatID$$aAllianz-Lizenz / DFG
000834120 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000834120 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOLOGY : 2015
000834120 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000834120 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000834120 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000834120 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000834120 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000834120 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000834120 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000834120 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNEURO-ONCOLOGY : 2015
000834120 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000834120 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x1
000834120 9201_ $$0I:(DE-82)080010_20140620$$kJARA-BRAIN$$lJARA-BRAIN$$x2
000834120 980__ $$ajournal
000834120 980__ $$aVDB
000834120 980__ $$aI:(DE-Juel1)INM-3-20090406
000834120 980__ $$aI:(DE-Juel1)INM-4-20090406
000834120 980__ $$aI:(DE-82)080010_20140620
000834120 980__ $$aUNRESTRICTED